Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Peter Radšel"'
Autor:
Misa Fister, Ursa Mikuz, Klemen Ziberna, Danilo Franco, Peter Radsel, Matjaz Bunc, Marko Noc, Tomaz Goslar
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0303376 (2024)
The early unfractionated heparin (UFH) treatment in patients with ST-elevation myocardial infarction (STEMI) is a single-center, open-label, randomized controlled trial. The study population are patients with STEMI that undergo primary percutaneous c
Externí odkaz:
https://doaj.org/article/d1303a94c0e94ac2a2da055ea880f92c
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Tachycardia-induced cardiomyopathy (T-CMP) related to supraventricular arrhythmia is a rare and often unrecognized cause of refractory cardiogenic shock. When rhythm control interventions are ineffective or no longer pursued, atrioventricular node ab
Externí odkaz:
https://doaj.org/article/40be36d151a84e4aa89d82453021378b
Publikováno v:
Zdravniški Vestnik, Vol 77, Iss 6-7 (2008)
BACKGROUND Coronary artery disease is the most common cause of sudden cardiac death. More then 50 % of patients die before reaching the hospital and at discharge survival rates remain aslow as 5 %. High mortality is mainly due to a cardiovascular col
Externí odkaz:
https://doaj.org/article/b465e8d2bdb34bf398b919e7c25b4a69
Autor:
Manca Ogrič, Polona Žigon, Snezna Sodin-Semrl, Mirjana Zlatković-Švenda, Marija Zdravković, Milica Ovuka, Tinka Švec, Katja Lakota, Peter Radšel, Žiga Rotar, Saša Čučnik
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 1; Pages: 211
Antiphospholipid antibodies (aPL) comprise a group of autoantibodies that reflect prothrombotic risk in antiphospholipid syndrome (APS) but may also be present in a small proportion of healthy individuals. They are often transiently elevated in infec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba9bdaa04814bf1f24c4a56a920e4747
https://pubmed.ncbi.nlm.nih.gov/36613655
https://pubmed.ncbi.nlm.nih.gov/36613655
Autor:
Tomaž Cankar, Mihela Krepek, Marinos Kosmopoulos, Peter Radšel, Demetris Yannopoulos, Marko Noc, Tomaž Goslar
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 21; Pages: 6452
Background: The use of veno-arterial extracorporeal membrane oxygenation (VA ECMO) for hemodynamic support is on the rise. Not much is known about the impact of extracorporeal membrane oxygenation (ECMO) and its complications on long-term survival an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::684a75eff8394301d19339339bcb2fe6
https://doi.org/10.3390/jcm11216452
https://doi.org/10.3390/jcm11216452